From Molecule to Medicine: Circular Manufacturing Opportunities for Ireland's Pharmaceutical Sector

Join us for the launch of CIRCULÉIRE's 12th Best Practice Sectoral Guide, From Molecule to Medicine: Circular Manufacturing Opportunities for Ireland's Pharmaceutical Sector. 

Pharmaceutical manufacturing is central to Ireland's economy, and it operates under some of the strictest quality and regulatory standards of any industry. The new guide explores how manufacturers can apply circular economy principles within those standards. It covers extending the life of equipment and products, designing waste out of processes, recovering valuable materials, and making packaging more sustainable. Case studies from companies including Pfizer, Eli Lilly, Novartis, Sanofi and Novo Nordisk show what is already working. 

Who should attend: Anyone working in or with the pharmaceutical sector, including operations, engineering, sustainability, quality and supply chain professionals, as well as policymakers, funders, researchers and students. 

What you'll gain: A clear introduction to why the circular economy matters for pharma, practical examples from leading manufacturers, and lessons you can apply in your own organisation. The full guide will be free to download on the day.

Thursday 22 October | 11:00AM – 12:00PM | Online | Free  Speakers: Paul McCormack Cooney (CIRCULÉIRE) and Dr Rabah Mouras (PMTC).  REGISTER NOW: https://us06web.zoom.us/webinar/register/WN_v9AuuqDqTdmO8-vpN-J1oA#/registration